Radiological or Nuclear Medical Countermeasure Tender - 141577532

Procurement Summary

Country: USA

Summary: Radiological or Nuclear Medical Countermeasure Product Development Support Pds

Deadline: 02 Jun 2026

Posting Date: 19 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 141577532

Document Ref. No.: 75N93026R00005

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Introduction
The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology, leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases.
NIAID, Division of Allergy, Immunology and Transplantation (DAIT) requires advanced product development by the Biomedical Advanced Research and Development Authority or acquisition under the Project BioShield Act of 2004.
Description
The National Institute of Allergy and Infectious Diseases (NIAID) intends to solicit proposals for a contract entitled “Radiological or Nuclear Medical Countermeasure Product Development Support (PDS)” to advance the development of candidate medical countermeasures (MCMs), including biodosimetric approaches to determine radiation exposure. NIAID anticipates that research and development studies supported by this RFP will advance candidate MCMs toward eventual FDA approval or licensure for acute radiation syndrome (ARS) or delayed effects of acute radiation exposure (DEARE).
It is anticipated that candidate MCMs will enter the evaluation and development pathway at various stages, from early research to post-marketing (for drugs or biologics that are already licensed or approved for other indications). The Contractor will collaborate with NIAID and, under the direction of NIAID, with organizations that have developed MCMs and with other federal authorities, including the Food and Drug Administration (FDA).
The proposals will be evaluated on the comprehensiveness, soundness, adequacy, and suitability of the proposed scientific approach and methodology used to support the advancement of candidate MCMs for the mitigation or treatment of ARS/DEARE towards FDA approval or licensure under the Animal Efficacy Rul...
Notice ID: 75n93026r00005

Department/Ind. Agency: health and human services, department of

Sub-tier: national institutes of health

Office: national institutes of health niaid

Product Service Code: an12 - health r&d services; health care services; applied research

NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Inactive Dates: jun 17, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice

Documents.zip